[HTML][HTML] An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C Yoshioka, Y Ito, N Nagai - Experimental and …, 2018 - spandidos-publications.com
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
[PDF][PDF] An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C YOSHIOKA, Y ITO, N NAGAI - kindai.repo.nii.ac.jp
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
[HTML][HTML] An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C Yoshioka, Y Ito, N Nagai - Experimental and Therapeutic …, 2018 - ncbi.nlm.nih.gov
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
[引用][C] An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C Yoshioka, Y Ito, N Nagai - Experimental and Therapeutic Medicine, 2017 - cir.nii.ac.jp
An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C YOSHIOKA, Y ITO, N NAGAI - ingentaconnect.com
Cilostazol (CLZ) is an antiplatelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly watersoluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly watersoluble drug and a strategy for increasing its …
An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats.
C Yoshioka, Y Ito, N Nagai - Experimental and Therapeutic …, 2017 - europepmc.org
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C Yoshioka, Y Ito, N Nagai - Experimental and therapeutic …, 2018 - pubmed.ncbi.nlm.nih.gov
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats.
C Yoshioka, Y Ito, N Nagai - Experimental & Therapeutic …, 2018 - search.ebscohost.com
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
[HTML][HTML] An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C Yoshioka, Y Ito, N Nagai - Experimental and …, 2018 - spandidos-publications.com
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats
C Yoshioka, Y Ito, N Nagai - Experimental and Therapeutic Medicine, 2018 - go.gale.com
Cilostazol (CLZ) is an anti-platelet agent that is generally used after the onset of cerebral
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …
infarction. However, CLZ is a poorly water-soluble drug and a strategy for increasing its …